208:
477:
29:
41:
522:
439:
Wellfelt K, Sköld AC, Wallin A, Danielsson BR (1999-04-01). "Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species".
404:
Wiesfeld AC, Crijns HJ, Bergstrand RH, Almgren O, Hillege HL, Lie KI (October 1993). "Torsades de pointes with
Almokalant, a new class III antiarrhythmic drug".
298:
561:
541:
515:
284:
546:
508:
318:
65:
326:
InChI=1S/C18H28N2O3S/c1-3-11-24(22)12-5-10-20(4-2)14-17(21)15-23-18-8-6-16(13-19)7-9-18/h6-9,17,21H,3-5,10-12,14-15H2,1-2H3
147:
187:
365:
176:
488:
361:
203:
556:
484:
82:
476:
551:
456:
421:
492:
136:
448:
413:
224:
91:
156:
207:
452:
535:
417:
116:
381:
369:
260:
127:
460:
20:
425:
102:
28:
167:
283:
274:
357:
192:
496:
343:
272:
259:
223:
218:
186:
166:
146:
126:
101:
81:
56:
40:
35:
115:
90:
73:4-(3-{Ethylamino}-2-hydroxypropoxy)benzonitrile
516:
8:
19:
523:
509:
399:
397:
206:
135:
27:
155:
393:
323:
303:
202:
70:
18:
175:
7:
473:
471:
306:O=S(CCC)CCCN(CC)CC(O)COc1ccc(C#N)cc1
106:
495:. You can help Knowledge (XXG) by
14:
562:Cardiovascular system drug stubs
475:
241:
235:
331:Key:ZMHOBBKJBYLXFR-UHFFFAOYSA-N
542:Drugs not assigned an ATC code
253:
247:
229:
1:
453:10.1016/s0890-6238(98)00066-5
418:10.1016/0002-8703(93)90726-p
368:. It has been found to have
578:
547:Potassium channel blockers
470:
219:Chemical and physical data
366:potassium channel blocker
339:
314:
294:
61:
26:
487:article relating to the
441:Reproductive Toxicology
406:American Heart Journal
489:cardiovascular system
23:
504:
503:
372:effects in rats.
351:
350:
285:Interactive image
188:CompTox Dashboard
16:Chemical compound
569:
525:
518:
511:
479:
472:
465:
464:
436:
430:
429:
412:(4): 1008–1011.
401:
347:
346:
287:
267:
255:
249:
243:
237:
231:
211:
210:
196:
194:
179:
159:
139:
119:
109:
108:
94:
31:
24:
22:
577:
576:
572:
571:
570:
568:
567:
566:
532:
531:
530:
529:
469:
468:
438:
437:
433:
403:
402:
395:
390:
378:
342:
340:
335:
332:
327:
322:
321:
310:
307:
302:
301:
290:
265:
252:
246:
240:
234:
214:
190:
182:
162:
142:
122:
105:
97:
77:
74:
69:
68:
52:
17:
12:
11:
5:
575:
573:
565:
564:
559:
554:
549:
544:
534:
533:
528:
527:
520:
513:
505:
502:
501:
480:
467:
466:
431:
392:
391:
389:
386:
385:
384:
377:
374:
360:used to treat
349:
348:
337:
336:
334:
333:
330:
328:
325:
317:
316:
315:
312:
311:
309:
308:
305:
297:
296:
295:
292:
291:
289:
288:
280:
278:
270:
269:
263:
257:
256:
250:
244:
238:
232:
227:
221:
220:
216:
215:
213:
212:
204:DTXSID40869693
199:
197:
184:
183:
181:
180:
172:
170:
164:
163:
161:
160:
152:
150:
144:
143:
141:
140:
132:
130:
124:
123:
121:
120:
112:
110:
99:
98:
96:
95:
87:
85:
79:
78:
76:
75:
72:
64:
63:
62:
59:
58:
54:
53:
51:
50:
46:
44:
38:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
574:
563:
560:
558:
555:
553:
550:
548:
545:
543:
540:
539:
537:
526:
521:
519:
514:
512:
507:
506:
500:
498:
494:
490:
486:
481:
478:
474:
462:
458:
454:
450:
447:(2): 93–101.
446:
442:
435:
432:
427:
423:
419:
415:
411:
407:
400:
398:
394:
387:
383:
380:
379:
375:
373:
371:
367:
363:
359:
355:
345:
338:
329:
324:
320:
313:
304:
300:
293:
286:
282:
281:
279:
276:
271:
264:
262:
258:
228:
226:
222:
217:
209:
205:
201:
200:
198:
189:
185:
178:
174:
173:
171:
169:
165:
158:
154:
153:
151:
149:
145:
138:
134:
133:
131:
129:
125:
118:
114:
113:
111:
104:
100:
93:
89:
88:
86:
84:
80:
71:
67:
60:
55:
48:
47:
45:
43:
39:
36:Clinical data
34:
30:
25:
497:expanding it
482:
444:
440:
434:
409:
405:
353:
352:
341:
177:ChEMBL362103
382:Vernakalant
370:teratogenic
364:. It is a
268: g·mol
92:123955-10-2
57:Identifiers
557:Sulfoxides
536:Categories
388:References
362:arrhythmia
354:Almokalant
273:3D model (
261:Molar mass
157:I9NG89L275
128:ChemSpider
83:CAS Number
66:IUPAC name
21:Almokalant
552:Nitriles
461:10213516
376:See also
344:(verify)
42:ATC code
426:8213422
225:Formula
137:2298526
117:3033962
103:PubChem
459:
424:
299:SMILES
266:352.49
168:ChEMBL
491:is a
483:This
356:is a
319:InChI
275:JSmol
493:stub
485:drug
457:PMID
422:PMID
358:drug
148:UNII
49:None
449:doi
414:doi
410:126
193:EPA
107:CID
538::
455:.
445:13
443:.
420:.
408:.
396:^
239:28
233:18
524:e
517:t
510:v
499:.
463:.
451::
428:.
416::
277:)
254:S
251:3
248:O
245:2
242:N
236:H
230:C
195:)
191:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
